These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 10950967

  • 1. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling.
    Haque SJ, Harbor PC, Williams BR.
    J Biol Chem; 2000 Aug 25; 275(34):26500-6. PubMed ID: 10950967
    [Abstract] [Full Text] [Related]

  • 2. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
    Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M, Alexander WS, Metcalf D, Hilton DJ, Nicola NA.
    EMBO J; 1999 Jan 15; 18(2):375-85. PubMed ID: 9889194
    [Abstract] [Full Text] [Related]

  • 3. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction.
    Losman JA, Chen XP, Hilton D, Rothman P.
    J Immunol; 1999 Apr 01; 162(7):3770-4. PubMed ID: 10201892
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D, Demoulin JB, Renauld JC.
    Biochem J; 2001 Jan 01; 353(Pt 1):109-116. PubMed ID: 11115404
    [Abstract] [Full Text] [Related]

  • 5. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling.
    Narazaki M, Fujimoto M, Matsumoto T, Morita Y, Saito H, Kajita T, Yoshizaki K, Naka T, Kishimoto T.
    Proc Natl Acad Sci U S A; 1998 Oct 27; 95(22):13130-4. PubMed ID: 9789053
    [Abstract] [Full Text] [Related]

  • 6. Suppressors of cytokine signalling: SOCS.
    Larsen L, Röpke C.
    APMIS; 2002 Dec 27; 110(12):833-44. PubMed ID: 12645661
    [Abstract] [Full Text] [Related]

  • 7. A family of cytokine-inducible inhibitors of signalling.
    Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ.
    Nature; 1997 Jun 26; 387(6636):917-21. PubMed ID: 9202125
    [Abstract] [Full Text] [Related]

  • 8. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation.
    Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G, Kile BT, Kent SB, Alexander WS, Metcalf D, Hilton DJ, Nicola NA, Baca M.
    Proc Natl Acad Sci U S A; 1999 Mar 02; 96(5):2071-6. PubMed ID: 10051596
    [Abstract] [Full Text] [Related]

  • 9. The suppressors of cytokine signalling (SOCS).
    Kile BT, Alexander WS.
    Cell Mol Life Sci; 2001 Oct 02; 58(11):1627-35. PubMed ID: 11706989
    [Abstract] [Full Text] [Related]

  • 10. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S, Chughtai N, Ali S.
    Mol Cell Endocrinol; 1999 Dec 20; 158(1-2):45-54. PubMed ID: 10630404
    [Abstract] [Full Text] [Related]

  • 11. SOCS: suppressors of cytokine signalling.
    Starr R, Hilton DJ.
    Int J Biochem Cell Biol; 1998 Oct 20; 30(10):1081-5. PubMed ID: 9785473
    [Abstract] [Full Text] [Related]

  • 12. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway.
    Cooney RN.
    Shock; 2002 Feb 20; 17(2):83-90. PubMed ID: 11837794
    [Abstract] [Full Text] [Related]

  • 13. Twenty proteins containing a C-terminal SOCS box form five structural classes.
    Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D, Nicola NA.
    Proc Natl Acad Sci U S A; 1998 Jan 06; 95(1):114-9. PubMed ID: 9419338
    [Abstract] [Full Text] [Related]

  • 14. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
    Hamanaka I, Saito Y, Yasukawa H, Kishimoto I, Kuwahara K, Miyamoto Y, Harada M, Ogawa E, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Masuda I, Yoshimura A, Nakao K.
    Circ Res; 2001 Apr 13; 88(7):727-32. PubMed ID: 11304496
    [Abstract] [Full Text] [Related]

  • 15. IL-4/IL-13 signaling beyond JAK/STAT.
    Jiang H, Harris MB, Rothman P.
    J Allergy Clin Immunol; 2000 Jun 13; 105(6 Pt 1):1063-70. PubMed ID: 10856136
    [Abstract] [Full Text] [Related]

  • 16. The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine action.
    Nicola NA, Greenhalgh CJ.
    Exp Hematol; 2000 Oct 13; 28(10):1105-12. PubMed ID: 11027828
    [Abstract] [Full Text] [Related]

  • 17. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling.
    Pezet A, Favre H, Kelly PA, Edery M.
    J Biol Chem; 1999 Aug 27; 274(35):24497-502. PubMed ID: 10455112
    [Abstract] [Full Text] [Related]

  • 18. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
    Kashiwada M, Giallourakis CC, Pan PY, Rothman PB.
    J Immunol; 2001 Dec 01; 167(11):6382-7. PubMed ID: 11714803
    [Abstract] [Full Text] [Related]

  • 19. Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction.
    Alexander WS, Starr R, Metcalf D, Nicholson SE, Farley A, Elefanty AG, Brysha M, Kile BT, Richardson R, Baca M, Zhang JG, Willson TA, Viney EM, Sprigg NS, Rakar S, Corbin J, Mifsud S, DiRago L, Cary D, Nicola NA, Hilton DJ.
    J Leukoc Biol; 1999 Oct 01; 66(4):588-92. PubMed ID: 10534114
    [Abstract] [Full Text] [Related]

  • 20. Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes.
    Yamasaki K, Hanakawa Y, Tokumaru S, Shirakata Y, Sayama K, Hanada T, Yoshimura A, Hashimoto K.
    J Invest Dermatol; 2003 Apr 01; 120(4):571-80. PubMed ID: 12648219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.